FOXO1 and alveolar rhabdomyosarcoma: Although it is possible to prevent ARMS metastasis by downregulating PAX3-FKHR, transcription factors are challenging drug targets, and currently there is no pharmacologic inhibitor of PAX3-FKHR available.